1. Home
  2. LONA vs IH Comparison

LONA vs IH Comparison

Compare LONA & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

HOLD

Current Price

$4.35

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Logo iHuman Inc.

IH

iHuman Inc.

SELL

Current Price

$1.16

Market Cap

58.8M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
LONA
IH
Founded
2011
1996
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
49.7M
58.8M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LONA
IH
Price
$4.35
$1.16
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $16.67
N/A
AVG Volume (30 Days)
★ 82.9K
2.1K
Earning Date
11-17-2026
09-29-2026
Dividend Yield
N/A
★ 8.77%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$7.30
Revenue Growth
N/A
N/A
52 Week Low
$2.21
$1.10
52 Week High
$14.21
$2.99

Technical Indicators

Market Signals
Indicator
LONA
IH
Relative Strength Index (RSI) 39.17 44.47
Support Level $4.39 $1.10
Resistance Level $9.78 $1.25
Average True Range (ATR) 0.45 0.03
MACD -0.01 0.00
Stochastic Oscillator 2.87 28.57

Price Performance

Historical Comparison
LONA
IH

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

Share on Social Networks: